{"nct_id":"NCT04428151","title":"Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2020-08-06","start_date_type":"ACTUAL","primary_completion_date":"2024-05-31","primary_completion_date_type":"ACTUAL","completion_date":"2025-12-22","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}